Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 70,000 | -373,000 | -721,000 | -36,000 | 120,000 | -- |
| Operating Revenue | 70,000 | -373,000 | -721,000 | -36,000 | 120,000 | -- |
| Cost Of Revenue | 74,000 | 74,000 | -- | -- | -337,000 | 91,000 |
| Gross Profit | -4,000 | -447,000 | -- | -- | 457,000 | 112,000 |
| Selling General And Administration | 112,000 | 144,000 | 112,000 | 418,000 | 73,000 | -- |
| General And Administrative Expense | 112,000 | 144,000 | 112,000 | 418,000 | 59,000 | -- |
| Research And Development | 0.00 | 0.00 | -- | 9,000 | 8,000 | 9,000 |
| Other Operating Expenses | -3.9M | -3.6M | 1.3M | 10.1M | -10.1M | -- |
| Operating Expense | -3.7M | -3.5M | 1.4M | 10.6M | -10.1M | -- |
| Operating Income | 3.7M | 3.0M | -2.2M | -10.6M | 10.5M | -- |
| EBIT | 3.7M | 3.0M | -2.2M | -10.6M | 10.5M | -- |
| Other Income Expense | 0.00 | -1,000 | 125,000 | 241,000 | -21,000 | -- |
| Other Non Operating Income Expenses | -- | -- | -- | -- | 0.00 | 7,000 |
| Special Income Charges | 0.00 | 0.00 | 0.00 | 351,000 | -8,000 | -- |
| Write Off | 0.00 | 0.00 | 0.00 | -351,000 | 0.00 | -- |
| Gain On Sale Of Security | 0.00 | -1,000 | 125,000 | -110,000 | -13,000 | -- |
| Pretax Income | 3.7M | 3.0M | -2.0M | -10.4M | 10.5M | -- |
| Tax Effect Of Unusual Items | 0.00 | -150.00 | 0.00 | 0.00 | -3,150 | -- |
| Net Income From Continuing And Discontinued Operation | 3.7M | 3.0M | -2.0M | -10.7M | 10.5M | -- |
| Net Income From Continuing Operation Net Minority Interest | 3.7M | 3.0M | -2.0M | -10.7M | 10.5M | -- |
| Net Income Including Noncontrolling Interests | 3.7M | 3.0M | -2.0M | -10.7M | 10.5M | -- |
| Net Income Common Stockholders | 3.7M | 3.0M | -2.0M | -10.7M | 10.5M | -- |
| Net Income | 3.7M | 3.0M | -2.0M | -10.7M | 10.5M | -- |
| EBITDA | 3.7M | 3.0M | -2.2M | -10.6M | 10.5M | -- |
| Normalized EBITDA | 3.7M | 3.0M | -2.3M | -10.9M | 10.6M | -- |
| Reconciled Depreciation | -- | -- | -- | -- | 21,000 | 0.00 |
| Basic EPS | -- | 0.17 | -0.12 | -0.68 | -- | -0.20 |
| Diluted EPS | -- | 0.17 | -0.12 | -0.68 | -- | -0.20 |
| Basic Average Shares | -- | 17.4M | 17.4M | 15.8M | -- | 15.3M |
| Diluted Average Shares | -- | 17.4M | 17.4M | 17.3M | -- | 17.8M |
| Total Unusual Items | 0.00 | -1,000 | 125,000 | 241,000 | -21,000 | -- |
| Total Unusual Items Excluding Goodwill | 0.00 | -1,000 | 125,000 | 241,000 | -21,000 | -- |
| Tax Rate For Calcs | 0.15 | 0.15 | 0.00 | 0.00 | 0.15 | -- |
| Normalized Income | 3.7M | 3.0M | -2.2M | -11.0M | 10.5M | -- |
| Diluted NI Availto Com Stockholders | 3.7M | 3.0M | -2.0M | -10.7M | 10.5M | -- |
| Net Income Continuous Operations | 3.7M | 3.0M | -2.0M | -10.4M | 10.5M | -- |
| Other Gand A | 112,000 | 144,000 | 112,000 | 418,000 | 244,000 | -- |
| Reconciled Cost Of Revenue | 74,000 | 74,000 | -- | -- | -337,000 | 91,000 |
| Salaries And Wages | 0.00 | 0.00 | 0.00 | 0.00 | -185,000 | -- |
| Selling And Marketing Expense | 0.00 | 0.00 | 0.00 | 0.00 | 14,000 | -- |
| Total Expenses | -3.7M | -3.4M | 1.4M | 10.6M | -10.4M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 506,000 | 823,000 | 665,000 | 98,000 | 12,000 | -- |
| Cash Cash Equivalents And Short Term Investments | 16.9M | 13.3M | 9.8M | 12.0M | 22.8M | -- |
| Cash Financial | 506,000 | 823,000 | 665,000 | 98,000 | 12,000 | -- |
| Other Short Term Investments | 16.4M | 12.5M | 9.1M | 11.9M | 22.8M | -- |
| Accounts Receivable | -- | -- | -- | -- | 0.00 | 60,000 |
| Receivables | 411,000 | 386,000 | 386,000 | 399,000 | 399,000 | -- |
| Prepaid Assets | 5,000 | 3,000 | 4,000 | 12,000 | 15,000 | -- |
| Current Assets | 17.7M | 14.3M | 10.6M | 12.5M | 23.5M | -- |
| Total Non Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Assets | 17.7M | 14.3M | 10.6M | 12.5M | 23.5M | -- |
| Accounts Payable | 74,000 | 103,000 | 53,000 | 137,000 | 90,000 | -- |
| Payables | 1.4M | 1.9M | 1.9M | 1.9M | 1.7M | -- |
| Payables And Accrued Expenses | 1.4M | 1.9M | 1.9M | 1.9M | 1.7M | -- |
| Other Current Liabilities | -- | -- | 83,000 | -- | 456,000 | 1.4M |
| Current Liabilities | 1.4M | 1.9M | 2.0M | 1.9M | 2.2M | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 17,000 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 1.4M | 1.9M | 2.0M | 1.9M | 2.2M | -- |
| Common Stock | 137.9M | 136.9M | 136.9M | 136.9M | 136.3M | -- |
| Capital Stock | 137.9M | 136.9M | 136.9M | 136.9M | 136.3M | -- |
| Additional Paid In Capital | 39.6M | 39.6M | 39.6M | 39.6M | 40.1M | -- |
| Retained Earnings | -164.6M | -168.3M | -171.3M | -169.3M | -158.6M | -- |
| Gains Losses Not Affecting Retained Earnings | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | -- |
| Other Equity Adjustments | 3.5M | 3.5M | 3.5M | 3.5M | 3.5M | -- |
| Common Stock Equity | 16.3M | 12.3M | 8.6M | 10.6M | 21.3M | -- |
| Stockholders Equity | 16.3M | 12.3M | 8.6M | 10.6M | 21.3M | -- |
| Total Equity Gross Minority Interest | 16.3M | 12.3M | 8.6M | 10.6M | 21.3M | -- |
| Minority Interest | -- | -- | -- | -- | 0.00 | -- |
| Total Capitalization | 16.3M | 12.3M | 8.6M | 10.6M | 21.3M | -- |
| Net Tangible Assets | 16.3M | 12.3M | 8.6M | 10.6M | 21.3M | -- |
| Tangible Book Value | 16.3M | 12.3M | 8.6M | 10.6M | 21.3M | -- |
| Working Capital | 16.3M | 12.3M | 8.6M | 10.6M | 21.3M | -- |
| Invested Capital | 16.3M | 12.3M | 8.6M | 10.6M | 21.3M | -- |
| Share Issued | 21.9M | 17.4M | 17.4M | 17.4M | 16.2M | -- |
| Ordinary Shares Number | 21.9M | 17.4M | 17.4M | 17.4M | 16.2M | -- |
| Assets Held For Sale Current | -- | -- | -- | -- | 0.00 | 21,000 |
| Duefrom Related Parties Current | 411,000 | 386,000 | 386,000 | 399,000 | 399,000 | -- |
| Dueto Related Parties Current | 1.3M | 1.8M | 1.9M | 1.8M | 1.6M | -- |
| Hedging Assets Current | 224,000 | 434,000 | 378,000 | 130,000 | 193,000 | -- |
| Loans Receivable | -- | -- | -- | -- | 0.00 | 0.00 |
| Other Equity Interest | -- | 750,000 | -- | -- | -- | -- |
| Restricted Cash | 152,000 | 149,000 | 50,000 | 12,000 | 70,000 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -564,000 | -493,000 | 606,000 | 27,000 | -15,000 | -- |
| Cash Flow From Continuing Operating Activities | -564,000 | -493,000 | 606,000 | 27,000 | -17,000 | -- |
| Depreciation And Amortization | -- | -- | -- | -- | 21,000 | 0.00 |
| Depreciation Amortization Depletion | -- | -- | -- | -- | 21,000 | 0.00 |
| Stock Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | -185,000 | -- |
| Change In Working Capital | -599,000 | -73,000 | 72,000 | -209,000 | -1.1M | -- |
| Changes In Account Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 60,000 | -- |
| Change In Receivables | -26,000 | 1,000 | 13,000 | 0.00 | 58,000 | -- |
| Change In Payables And Accrued Expense | -571,000 | 8,000 | -32,000 | 244,000 | -295,000 | -- |
| Change In Payable | -571,000 | 8,000 | -32,000 | 244,000 | -295,000 | -- |
| Change In Other Working Capital | -- | -83,000 | -- | -- | -- | -824,000 |
| Change In Other Current Liabilities | -- | -- | -- | -456,000 | -920,000 | -824,000 |
| Other Non Cash Items | 52,000 | -201,000 | 631,000 | 663,000 | 1.0M | -- |
| Purchase Of PPE | -- | -- | -- | -- | -- | 0.00 |
| Net PPE Purchase And Sale | -- | -- | -- | -- | -- | 0.00 |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Cash Flow From Continuing Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Repurchase Of Capital Stock | -- | -- | -- | -- | 0.00 | 0.00 |
| Net Common Stock Issuance | -- | -- | -- | -- | 0.00 | 0.00 |
| Common Stock Payments | -- | -- | -- | -- | 0.00 | 0.00 |
| Financing Cash Flow | 250,000 | 750,000 | 0.00 | 0.00 | 0.00 | -- |
| Cash Flow From Continuing Financing Activities | 250,000 | 750,000 | 0.00 | 0.00 | 0.00 | -- |
| Effect Of Exchange Rate Changes | 0.00 | 0.00 | -1,000 | 1,000 | -2,000 | -- |
| Changes In Cash | -314,000 | 257,000 | 606,000 | 27,000 | -15,000 | -- |
| Beginning Cash Position | 972,000 | 715,000 | 110,000 | 82,000 | 99,000 | -- |
| End Cash Position | 658,000 | 972,000 | 715,000 | 110,000 | 82,000 | -- |
| Free Cash Flow | -564,000 | -493,000 | 606,000 | 27,000 | -15,000 | -- |
| Interest Paid Supplemental Data | -- | 0.00 | -22,000 | 27,000 | -- | 127,000 |
| Amortization Cash Flow | -- | -- | -- | -- | 21,000 | 0.00 |
| Amortization Of Intangibles | -- | -- | -- | -- | 21,000 | 0.00 |
| Asset Impairment Charge | 0.00 | -- | -- | -- | 0.00 | 1.3M |
| Change In Account Payable | -29,000 | 50,000 | -84,000 | 47,000 | -49,000 | -- |
| Change In Prepaid Assets | -2,000 | 1,000 | 8,000 | 3,000 | 20,000 | -- |
| Gain Loss On Investment Securities | 99,000 | 373,000 | 721,000 | 36,000 | -123,000 | -- |
| Net Foreign Currency Exchange Gain Loss | 0.00 | 0.00 | -110,000 | 110,000 | 14,000 | -- |
| Net Income From Continuing Operations | 3.7M | 3.0M | -2.0M | -10.7M | 10.5M | -- |
| Net Other Investing Changes | -- | -- | -- | -- | 0.00 | 0.00 |
| Operating Gains Losses | 99,000 | 373,000 | 611,000 | 146,000 | -109,000 | -- |
| Proceeds From Stock Option Exercised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Provisionand Write Offof Assets | -- | -- | -- | -- | 0.00 | 0.00 |
| Unrealized Gain Loss On Investment Securities | -3.9M | -3.6M | 1.3M | 10.1M | -10.1M | -- |